Signature Series 2019

Public Briefing Cell and gene therapies are a promising frontier in biomedical innovation that have the potential to cure deadly and debilitating diseases. Over the past two years, several breakthrough therapies that treat cancers and genetic diseases have been approved by the FDA. Today there are more than 300 cell and gene therapies in development. […]

Public Half-Day Summit  Along with multiple efforts to define and achieve value-based care across the public and private sectors, unprecedented innovations in technology and medicine are continuously being introduced that challenge current paradigms for health care financing and delivery. During this summit, keynote speakers and panel experts explored the latest advancements and the remaining challenges […]

Public Briefing It has become increasingly clear that efforts to improve quality, lower costs, and enhance patient satisfaction cannot succeed without addressing socioeconomic status and nonmedical drivers of health—often called “social determinants of health”. However, the financing and oversight of holistic community initiatives is complicated, as they often involve a spectrum of municipal services, private […]

Public Half-Day Summit  This first topic examined the impact of nonmedical drivers of health-often called “social determinants of health”, on patients and the health system. It has become increasingly clear that efforts to improve quality, lower costs, and enhance patient satisfaction cannot succeed without addressing socio-economic status and nonmedical drivers of health such as housing, […]